Inhaled Treatment for Bronchopulmonary Dysplasia - Trial NCT04619602
Access comprehensive clinical trial information for NCT04619602 through Pure Global AI's free database. This Phase 1 trial is sponsored by University Hospitals Cleveland Medical Center and is currently Not yet recruiting. The study focuses on Bronchopulmonary Dysplasia. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University Hospitals Cleveland Medical Center
Timeline & Enrollment
Phase 1
Jul 01, 2022
Oct 01, 2024
Primary Outcome
Treatment Emergent Adverse Events
Summary
The primary objective of this study is to provide expanded access of S-nitrosylation therapy
 for the treatment of bronchopulmonary dysplasia
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04619602
Non-Device Trial